- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05144438
Advice Protocol to Reduce the Level of Exposure to Metallic Trace Elements (ETM) (ETM)
October 18, 2022 updated by: Elsan
Prospective Evaluation of the Effectiveness of a Counseling Protocol to Reduce the Level of Exposure to Metallic Trace Elements (ETM)
A French company (Toxseek, France, has developed a scientifically validated screening test based on a capillary determination of pollutants on a 3 cm lock of hair.
The results of this screening allow physicians to discuss with their patients the question of environmental health and provide them with personalized behavioral advice in an attempt to eliminate the source of the pollutants identified.The main objective of the study is to assess the effectiveness of behavioral counseling on reducing the level of exposure to metal-type environmental pollutants (MTE) in pregnant women or women planning to have children.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
185
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Saint-Rémy-de-Provence, France, 13210
- Pôle médical Saint Bernard
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women, over 18 years old, pregnant (first trimester) or desires conception
Description
Inclusion Criteria:
- Women over 18 years old
- Patient with desire to conceive
- 1st trimester of pregnancy
- Patient having been informed of the study and not opposing the use of the data collected
- Affiliate or beneficiary of a social security scheme
Exclusion Criteria:
- Women under 18 years old
- 2nd and 3rd trimester of pregnancy
- Patient objecting to the use of the data collected
- Protected patient: adult under tutorship, curatorship or other protection legal, deprived of liberty by judicial or administrative decision
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pregnant women or woman in desire for conception
Towseek test : hair taking different questionnaires : environmental questionnaire, compliance questionnaire
|
Hair taking
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients who reduced their level of exposure within 4 months of metal avoidance advice.
Time Frame: 4 months
|
The patient will be considered "successful" for the reduction of the exposure level, if all the metals with a "risky" exposure level during the 1st screening have gone to an exposure level "to be monitored" or "acceptable" during the 2nd screening.
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 3, 2021
Primary Completion (Actual)
September 3, 2022
Study Completion (Actual)
September 30, 2022
Study Registration Dates
First Submitted
November 23, 2021
First Submitted That Met QC Criteria
November 23, 2021
First Posted (Actual)
December 3, 2021
Study Record Updates
Last Update Posted (Actual)
October 19, 2022
Last Update Submitted That Met QC Criteria
October 18, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 2020-A01954-35
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metallic Trace Elements
-
Rabin Medical CenterRecruiting
-
Assiut UniversityRecruitingGood Responders According to Guidelines Who Wre Charectarized by AMH>0.8ng/dl | Trace Elements in ICSI CasesEgypt
-
Cairo UniversityCompletedTrace Elements Levels After Breast Cancer RadiotherapyEgypt
-
The Hospital for Sick ChildrenRare Disease Foundation Microgrant competitionCompleted
-
Nantes University HospitalRecruitingClinical Trial Incorporating Decentralized ElementsFrance
-
Minia UniversityRecruitingEffects of the ElementsEgypt
-
Peking Union Medical College HospitalCompleted
-
General Hospital PulaCompletedEffects of the Elements
-
You First ServicesCompletedMedication Associated Metallic Taste , DysgeusiaUnited States
-
Hamilton Health Sciences CorporationLondon Health Sciences CentreCompletedRenal Insufficiency, Chronic | Zinc Deficiency | Trace Element Excess | Trace Element DeficiencyCanada
Clinical Trials on Toxseek test
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingInfantile Spinal Muscular Atrophy | Spinal Amyotrophy | Juvenile Spinal Muscular AtrophyFrance
-
Groupe Hospitalier Mutualiste de GrenobleFondation de l'AvenirCompleted
-
Recep Tayyip Erdogan University Training and Research...Completed
-
Yonsei UniversityCompletedPostprandial Hyperglycemia
-
University of FloridaCompletedParkinson Disease (PD)United States
-
Clinical Nutrition Research Centre, SingaporeCompleted
-
University of MichiganCompletedAntidepressants Causing Adverse Effects in Therapeutic UseUnited States
-
University of BaghdadCompletedSexual Behavior | Sexual Orientation Conflict Disorder | Sexual Arousal Disorder | Sexual Orientation | Sexual; Orientation, Relationship DisorderIraq
-
French National Agency for Research on AIDS and...Completed